UNSPSC 51282207: Cefotetan sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C17H15N7O8S4.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0GXP746VXB, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6r-(6alpha,7alpha))- but more generally known as cefotetan disodium, which bears US NIH Compound Identifier 53024.

UNSPSC 51282207 Cefotetan sodium is a Commodity code capturing individual pharmaceutical products and preparations, but the recent state and local opportunities tagged under it reflect a much broader procurement landscape: naloxone and drug deactivation systems for public health initiatives, first-aid and emergency medical supplies for fire departments, generic pharmaceuticals and OTC products distributed through cooperative purchasing agreements, and direct-to-manufacturer prescription programs. The code's nominal scope — a specific antibiotic compound — diverges significantly from what state and local buyers are actually acquiring under this identifier. The issuing bodies soliciting pharmaceutical-related goods span state health agencies (Texas Health and Human Services Commission), county health departments (Seminole County, Florida), city fire and rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across Minnesota and Oregon). The issuing-body mix shows no single dominant repeat buyer; activity spans independent county health procurement, municipal fire department acquisition, state-level pharmacy benefit program development, and regional cooperative arrangements.

Geographic activity centers on Florida (Seminole County's naloxone and drug deactivation systems procurement), Texas (HHS Commission's direct-to-manufacturer prescription RFI), and the Minnesota-Oregon corridor (MMCAP cooperative purchasing). Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, due July 26, 2023; the City of Tampa's IFB for 169 line items of medical and first-aid supplies for the Fire Department Rescue Division, due March 13, 2026, with an estimated contract value of $700,000 and a 5% SLBE bid discount; the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, distributed through authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson); and the Texas HHS Commission's RFI for direct-to-manufacturer prescription capabilities, issued April 3, 2026. The code shows limited topical relevance to cefotetan sodium procurement specifically; opportunities are pharmaceutical and medical supply acquisitions that may have been mislabeled at posting.